Physician profile
Spencer L Eagan
NPI 1881785772
$7,123.64
in general payments reported to CMS, 2019-2025
29 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $193 · 2021: $2,579 · 2022: $1,130 · 2023: $1,344 · 2024: $253 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515 · Travel and Lodging: $572 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,514.53 |
| Travel and Lodging | $571.70 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,456.13 | 2021-2025 | |
| Sientra, INC. | $1,502.60 | 2021-2022 | |
| Mentor Worldwide LLC | $723.00 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $379.59 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Botox |
| Allergan, INC. | $213.66 | 2019-2022 | |
| Motiva USA, LLC | $205.13 | 2025 | |
| Integra Lifesciences Corporation | $180.08 | 2022-2023 | Durasorb Monofilament Mesh, Tenoglide |
| Davol INC. | $163.66 | 2022 | |
| Kerecis Limited | $145.45 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Endologix LLC | $123.16 | 2023 | |
| Endo Pharmaceuticals INC. | $114.58 | 2021-2024 | Xiaflex |
| Endo USA, INC. | $96.19 | 2024-2025 | Xiaflex |
| Intersect Ent, INC. | $92.02 | 2021-2022 | |
| Axogen | $83.51 | 2019 | |
| Stryker Corporation | $79.45 | 2022-2024 | Scopis Ent |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $70.79 | 2025 | Daxxify |
| Tela Bio, INC. | $68.28 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novo Nordisk INC | $62.14 | 2025 | Wegovy |
| Lifenet Health | $48.95 | 2023 | |
| Abbott Laboratories | $44.78 | 2023 | Cardiomems |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Acclarent, INC | $35.38 | 2022 | |
| Merck Sharp & Dohme LLC | $32.49 | 2023 | |
| Hologic Sales and Service, LLC | $31.75 | 2024 | Coolseal Generator |
| Genzyme Corporation | $30.62 | 2025 | |
| Becton, Dickinson and Company | $28.75 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.32 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $23.96 | 2025 | |
| Glaxosmithkline, LLC. | $23.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Eagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.